October 6, 2005
Vaccine for Cervical Cancer
The first large study of an experimental cervical cancer vaccine found it was 100 percent effective, in the short term, at blocking the most common forms of the disease, drugmaker Merck & Co. (MRK) said Thursday.
(excite.com)
